The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease

Journal of the American Geriatrics Society
Linda O NicholsResources for Enhancing Alzheimer's Caregivers Health II Investigators

Abstract

To examine the cost-effectiveness of a randomized, clinical trial of a home-based intervention for caregivers of people with dementia. This cost-effectiveness analysis examined Resources for Enhancing Alzheimer's Caregivers Health (REACH II), a multisite, randomized, clinical trial, from June 2002 through December 2004, funded by the National Institute on Aging and the National Institute of Nursing Research, of a behavioral intervention to decrease caregivers' stress and improve management of care recipient behavioral problems. Community-dwelling dementia caregiving dyads from the Memphis REACH II site. Of Memphis' random sample of 55 intervention and 57 control black and white dyads, 46 in each arm completed without death or discontinuation. Family caregivers were aged 21 and older, lived with the care recipient, and had provided 4 or more hours of care per day for 6 months or longer. Care recipients were cognitively and functionally impaired. Twelve individual sessions (9 home sessions and 3 telephone sessions) supplemented by five telephone support-group sessions. Control caregivers received two "check in" phone calls. Incremental cost-effectiveness ratio (ICER), the additional cost to bring about one additional unit of bene...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Oct 1, 1992·The American Journal of Orthopsychiatry·M S LabrecqueR W Toseland
Jan 1, 1991·International Psychogeriatrics·H Brodaty, K E Peters
Dec 2, 1989·BMJ : British Medical Journal·H Brodaty, M Gresham
Dec 1, 1980·The Gerontologist·S H ZaritJ Bach-Peterson
Feb 1, 1995·Neurology·J Corey-BloomD J Lanska
Aug 1, 1994·American Journal of Public Health·R L Ernst, J W Hay
Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell
Jan 1, 1996·International Psychogeriatrics·M L Wykle
Feb 1, 1997·The Gerontologist·M S BourgeoisB Palmer
May 26, 1998·Medical Care·A ElixhauserB R Luce
Nov 29, 2002·Dementia and Geriatric Cognitive Disorders·G M LeungL W Chu
May 22, 2003·Journal of the American Geriatrics Society·Howard FeldmanUNKNOWN Donepezil MSAD Study Investigators Group
Aug 20, 2003·Archives of Neurology·Liesi E HebertDenis A Evans
Jun 24, 2004·International Journal of Technology Assessment in Health Care·Rachael L Fleurence
Nov 24, 2004·American Journal of Alzheimer's Disease and Other Dementias·Brooke S HarrowLinda O Nichols
Nov 23, 2006·Annals of Internal Medicine·Kenneth E Covinsky, C Bree Johnston
Jun 1, 1992·Journal of Gerontological Social Work·Gary T Deimling

❮ Previous
Next ❯

Citations

Nov 16, 2010·Der Nervenarzt·S Klöppel
Mar 31, 2012·The Gerontologist·Courtney Harold Van HoutvenLinda Lindsey Davis
Dec 9, 2010·Clinical Nurse Specialist CNS·Tamilyn BakasMichael T Weaver
Feb 9, 2013·Clinical Nurse Specialist CNS·Yvonne Yueh-Feng LuJoan E Haase
Oct 15, 2008·Current Opinion in Psychiatry·Guk-Hee Suh, Changsu Han
Oct 8, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David B HoganLilian Thorpe
Oct 7, 2011·The Primary Care Companion to CNS Disorders·Hema KannanCharles D Petrie
Apr 22, 2014·Clinical Interventions in Aging·Timothy KwokFlorence Ho
Feb 4, 2010·The Journal of Nutrition, Health & Aging·F NourhashémiB Vellas
Aug 24, 2011·Issues in Mental Health Nursing·Lori I KiddDiana L Morris
Dec 29, 2013·The Gerontologist·Francisco I Salgado-GarcíaFrank Andrasik
Nov 16, 2014·The Gerontologist·Linda O NicholsMarshall J Graney
Sep 6, 2012·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·Eva K ParkerSharon K Ostwald
Jul 26, 2015·Health Economics Review·Chloé Gervès-PinquiéJoel Ankri
Mar 21, 2015·Journal of Evidence-informed Social Work·Eunyoung Lee
Mar 12, 2011·International Journal of Aging & Human Development·Linda O NicholsJeffrey Zuber
Mar 16, 2017·Journal of the American Geriatrics Society·Linda O NicholsTeresa M Waters
Oct 26, 2013·Dementia and Geriatric Cognitive Disorders·Rikke SøgaardGunhild Waldemar
Jun 25, 2017·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Elizabeth B FauthMary Mittelman
Aug 14, 2012·International Journal of Geriatric Psychiatry·Martin KnappRenee Romeo
Jul 22, 2014·International Journal of Geriatric Psychiatry·Josie DixonMartin Knapp
Nov 16, 2018·Aging & Mental Health·Nicole Nehrig, Cory K Chen
Nov 13, 2013·PharmacoEconomics·Renske J HoefmanWerner Brouwer
Jan 11, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Martin Knapp, Gloria Wong
Mar 19, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Carolyn W ZhuYaakov Stern
Jan 12, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Anders WimoUNKNOWN Alzheimer Disease International
Oct 1, 2019·Alzheimer Disease and Associated Disorders·Melissa J Armstrong, Slande Alliance
Mar 8, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P Krolak-SalmonV Dauphinot
Jun 7, 2017·Translational Behavioral Medicine·Jennifer Martindale-AdamsLinda O Nichols
Feb 7, 2019·American Journal of Alzheimer's Disease and Other Dementias·Cory K ChenAlyssa L Baer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.